ArticleBMC medical imaging2026
MDPNet: a multi-scale difference perception network for esophageal cancer segmentation in CT images.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate segmentation of esophageal cancers in CT images is crucial for disease treatment planning but remains difficult due to variable tumor morphology, low contrast with surrounding tissues, and blurred boundaries. We propose MDPNet, a Multi-scale Difference Perception Network for accurate esophageal cancer segmentation in CT images. MDPNet integrates three key modules, a Dynamic Feature Enhancement (DFE) strategy for global and local context fusion, a Cross-level Difference Modeling (CDM) module to highlight foreground-background differences, and a Multi-stage Foreground Enhancement (MFE) mechanism for progressive boundary refinement. Experiments on the self-built ECD 2D dataset and an external test set show that MDPNet achieves the best performance among state-of-the-art methods, with Dice coefficients of 0.82 and 0.78, respectively. MDPNet effectively improves segmentation accuracy and generalization, demonstrating preliminary generalization capability on our multi-center test sets, suggesting its potential as a decision-support tool.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.